WALZ; Juliane

Patent Applications and Registrations

Patent applications and USPTO patent grants for WALZ; Juliane.The latest application filed is for "novel cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers".

Company Profile

32.15.17

WALZ; Juliane - Tuebingen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers App 20210107941 - RAMMENSEE; Hans-Georg ; et al.	2021-04-15
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Grant 10,925,949 - Rammensee , et al. February 23, 2	2021-02-23
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Grant 10,919,933 - Rammensee , et al. February 16, 2	2021-02-16
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Grant 10,906,938 - Rammensee , et al. February 2, 2	2021-02-02
Novel Immunotherapy Against Several Tumors Of The Blood, Such As Acute Myeloid Leukemia (aml) App 20210023189 - RAMMENSEE; Hans-Georg ; et al.	2021-01-28
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Grant 10,898,562 - Rammensee , et al. January 26, 2	2021-01-26
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Grant 10,899,794 - Rammensee , et al. January 26, 2	2021-01-26
Novel Immunotherapy Against Several Tumors Of The Blood, Such As Acute Myeloid Leukemia (aml) App 20210008189 - RAMMENSEE; Hans-Georg ; et al.	2021-01-14
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) Grant 10,875,892 - Walz , et al. December 29, 2	2020-12-29
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml) Grant 10,813,985 - Rammensee , et al. October 27, 2	2020-10-27
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll) App 20200325174 - WALZ; Juliane ; et al.	2020-10-15
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Grant 10,799,571 - Rammensee , et al. October 13, 2	2020-10-13
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers App 20200308225 - RAMMENSEE; Hans-Georg ; et al.	2020-10-01
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers App 20200308226 - RAMMENSEE; Hans-Georg ; et al.	2020-10-01
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers App 20200308227 - RAMMENSEE; Hans-Georg ; et al.	2020-10-01
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Grant 10,781,233 - Rammensee , et al. Sept	2020-09-22
Novel Immunotherapy Against Several Tumors Of The Blood, Such As Acute Myeloid Leukemia (aml) App 20200268862 - RAMMENSEE; Hans-Georg ; et al.	2020-08-27
Novel Immunotherapy Against Several Tumors Of The Blood, Such As Acute Myeloid Leukemia (aml) App 20200254078 - Kind Code	2020-08-13
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) Grant 10,730,910 - Walz , et al.	2020-08-04
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Grant 10,668,137 - Rammensee , et al.	2020-06-02
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll) App 20200157148 - WALZ; Juliane ; et al.	2020-05-21
Novel Immunotherapy Against Several Tumors Of The Blood, Such As Acute Myeloid Leukemia (aml) App 20200093905 - RAMMENSEE; Hans-Georg ; et al.	2020-03-26
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) Grant 10,570,175 - Walz , et al. Feb	2020-02-25
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Grant 10,525,115 - Rammensee , et al. J	2020-01-07
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) Grant 10,450,346 - Walz , et al. Oc	2019-10-22
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll) App 20190284233 - WALZ; Juliane ; et al.	2019-09-19
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll) App 20190284234 - WALZ; Juliane ; et al.	2019-09-19
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers App 20190284236 - Rammensee; Hans-Georg ; et al.	2019-09-19
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers App 20190284235 - RAMMENSEE; Hans-Georg ; et al.	2019-09-19
Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) App 20190275130 - RAMMENSEE; Hans-Georg ; et al.	2019-09-12
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) Grant 10,364,271 - Walz , et al.	2019-07-30
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll) App 20190055286 - Walz; Juliane ; et al.	2019-02-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.